Clinical Trial

Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The overall aim of this research proposal is to explore the feasibility and acceptability of home antenatal maternal-fetal monitoring technology within a high-risk pregnancy group. The investigators hypothesise that home monitoring is feasible and acceptable to both pregnant women and HCPs. 50 women from a single site will be recruited to use a home cardiotocography (CTG) device alongside routine antenatal care. Participants will use this device once a week, for an hour at a time, for up to 6 weeks or until delivery. The primary outcome is 20 minutes of continuous monitoring. Additional outcomes assess acceptability, adherence and safety.
Trial Details
NCT Number NCT07124325
Lead Sponsor Birmingham Women's NHS Foundation Trust
Conditions Pregnancy, High Risk, Telemonitoring, Telemedicine, Cardiotocography
Enrollment 50 participants
Start Date 2025-06-11
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-15